Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella; Eleni Frangou; Sharon B Love; Gail Busza; Clive Holmes; Craig Ritchie; Robert Lawrence; Brady McFarlane; George Tadros; Basil H Ridha; Carol Bannister; Zuzana Walker; Hilary Archer; Elizabeth Coulthard; Ben R Underwood; Aparna Prasanna; Paul Koranteng; Salman Karim; Kehinde Junaid; Bernadette McGuinness; Ramin Nilforooshan; Ajay Macharouthu; Andrew Donaldson; Simon Thacker; Gregor Russell; Naghma Malik; Vandana Mate; Lucy Knight; Sajeev Kshemendran; John Harrison; Christian Hölscher; David J Brooks; Anthony Peter Passmore; Clive Ballard; Paul Edison

doi:10.1186/s13063-020-04608-4

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H Ridha, Carol Bannister, Zuzana Walker, Hilary Archer, Elizabeth Coulthard, Ben R Underwood, Aparna Prasanna, Paul Koranteng, Salman Karim, Kehinde Junaid, Bernadette McGuinnessRamin Nilforooshan, Ajay Macharouthu, Andrew Donaldson, Simon Thacker, Gregor Russell, Naghma Malik, Vandana Mate, Lucy Knight, Sajeev Kshemendran, John Harrison, Christian Hölscher, David J Brooks, Anthony Peter Passmore, Clive Ballard, Paul Edison

Aston Medical School

Research output: Contribution to journal › Correction › peer-review

Abstract

After publication of our article [1] the authors have notified us that the name of Prof. Christian Hölscher had been inadvertently forgotten when compiling the list of authors. Dr. Hölscher developed the concept of testing liraglutide in Alzheimer’s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer ociety UK grant that partially funds the study.

Original language	English
Article number	660
Number of pages	1
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-020-04608-4
Publication status	Published - 19 Jul 2020

Access to Document

10.1186/s13063-020-04608-4Licence: CC BY 3.0

Cite this

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K., ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21(1), Article 660. https://doi.org/10.1186/s13063-020-04608-4

@article{47ec74dfb05f45fe880d6f30afc385cc,

title = "Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)",

abstract = "After publication of our article [1] the authors have notified us that the name of Prof. Christian H{\"o}lscher had been inadvertently forgotten when compiling the list of authors. Dr. H{\"o}lscher developed the concept of testing liraglutide in Alzheimer{\textquoteright}s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer ociety UK grant that partially funds the study.",

author = "Femminella, {Grazia Daniela} and Eleni Frangou and Love, {Sharon B} and Gail Busza and Clive Holmes and Craig Ritchie and Robert Lawrence and Brady McFarlane and George Tadros and Ridha, {Basil H} and Carol Bannister and Zuzana Walker and Hilary Archer and Elizabeth Coulthard and Underwood, {Ben R} and Aparna Prasanna and Paul Koranteng and Salman Karim and Kehinde Junaid and Bernadette McGuinness and Ramin Nilforooshan and Ajay Macharouthu and Andrew Donaldson and Simon Thacker and Gregor Russell and Naghma Malik and Vandana Mate and Lucy Knight and Sajeev Kshemendran and John Harrison and Christian H{\"o}lscher and Brooks, {David J} and Passmore, {Anthony Peter} and Clive Ballard and Paul Edison",

year = "2020",

month = jul,

day = "19",

doi = "10.1186/s13063-020-04608-4",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

Femminella, GD, Frangou, E, Love, SB, Busza, G, Holmes, C, Ritchie, C, Lawrence, R, McFarlane, B, Tadros, G, Ridha, BH, Bannister, C, Walker, Z, Archer, H, Coulthard, E, Underwood, BR, Prasanna, A, Koranteng, P, Karim, S, Junaid, K, McGuinness, B, Nilforooshan, R, Macharouthu, A, Donaldson, A, Thacker, S, Russell, G, Malik, N, Mate, V, Knight, L, Kshemendran, S, Harrison, J, Hölscher, C, Brooks, DJ, Passmore, AP, Ballard, C & Edison, P 2020, 'Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)', Trials, vol. 21, no. 1, 660. https://doi.org/10.1186/s13063-020-04608-4

TY - JOUR

T1 - Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

AU - Femminella, Grazia Daniela

AU - Frangou, Eleni

AU - Love, Sharon B

AU - Busza, Gail

AU - Holmes, Clive

AU - Ritchie, Craig

AU - Lawrence, Robert

AU - McFarlane, Brady

AU - Tadros, George

AU - Ridha, Basil H

AU - Bannister, Carol

AU - Walker, Zuzana

AU - Archer, Hilary

AU - Coulthard, Elizabeth

AU - Underwood, Ben R

AU - Prasanna, Aparna

AU - Koranteng, Paul

AU - Karim, Salman

AU - Junaid, Kehinde

AU - McGuinness, Bernadette

AU - Nilforooshan, Ramin

AU - Macharouthu, Ajay

AU - Donaldson, Andrew

AU - Thacker, Simon

AU - Russell, Gregor

AU - Malik, Naghma

AU - Mate, Vandana

AU - Knight, Lucy

AU - Kshemendran, Sajeev

AU - Harrison, John

AU - Hölscher, Christian

AU - Brooks, David J

AU - Passmore, Anthony Peter

AU - Ballard, Clive

AU - Edison, Paul

PY - 2020/7/19

Y1 - 2020/7/19

N2 - After publication of our article [1] the authors have notified us that the name of Prof. Christian Hölscher had been inadvertently forgotten when compiling the list of authors. Dr. Hölscher developed the concept of testing liraglutide in Alzheimer’s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer ociety UK grant that partially funds the study.

AB - After publication of our article [1] the authors have notified us that the name of Prof. Christian Hölscher had been inadvertently forgotten when compiling the list of authors. Dr. Hölscher developed the concept of testing liraglutide in Alzheimer’s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer ociety UK grant that partially funds the study.

UR - https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04608-4

UR - http://www.scopus.com/inward/record.url?scp=85088352031&partnerID=8YFLogxK

U2 - 10.1186/s13063-020-04608-4

DO - 10.1186/s13063-020-04608-4

M3 - Correction

C2 - 32684162

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 660

ER -

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Abstract

Access to Document

Other files and links

Fingerprint

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: Study protocol for a randomised controlled trial (ELAD study)

Cite this